Hiroki Kusumoto

1.2k total citations
54 papers, 952 citations indexed

About

Hiroki Kusumoto is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Hiroki Kusumoto has authored 54 papers receiving a total of 952 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 16 papers in Molecular Biology. Recurrent topics in Hiroki Kusumoto's work include Gastric Cancer Management and Outcomes (12 papers), Colorectal Cancer Treatments and Studies (12 papers) and Biochemical and Molecular Research (5 papers). Hiroki Kusumoto is often cited by papers focused on Gastric Cancer Management and Outcomes (12 papers), Colorectal Cancer Treatments and Studies (12 papers) and Biochemical and Molecular Research (5 papers). Hiroki Kusumoto collaborates with scholars based in Japan, United States and Germany. Hiroki Kusumoto's co-authors include Yoshihiko Maehara, Keizō Sugimachi, Hideaki Anai, Tetsuya Kusumoto, Motofumi Yoshida, Masaru Haraguchi, Ikuo Takahashi, Takeshi Okamura, Ikuo Takahashi and Kazuya Endo and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer.

In The Last Decade

Hiroki Kusumoto

53 papers receiving 912 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroki Kusumoto Japan 18 369 355 296 219 140 54 952
Zuli Yang China 18 442 1.2× 290 0.8× 176 0.6× 297 1.4× 130 0.9× 44 963
Koushiro Ohtsubo Japan 19 452 1.2× 584 1.6× 319 1.1× 223 1.0× 75 0.5× 69 1.1k
Kanenori Endo Japan 17 369 1.0× 365 1.0× 332 1.1× 148 0.7× 28 0.2× 37 890
Özgül Sağol Türkiye 20 325 0.9× 461 1.3× 303 1.0× 210 1.0× 67 0.5× 102 1.2k
R. Kath Germany 18 433 1.2× 454 1.3× 187 0.6× 176 0.8× 93 0.7× 55 1.3k
Nigel C. Bird United Kingdom 17 373 1.0× 467 1.3× 260 0.9× 150 0.7× 48 0.3× 28 1.1k
Xiang Hu China 21 230 0.6× 474 1.3× 173 0.6× 302 1.4× 59 0.4× 62 979
Liangliang Wu China 18 370 1.0× 337 0.9× 202 0.7× 330 1.5× 81 0.6× 67 1.0k
Martin Werner Germany 12 319 0.9× 252 0.7× 226 0.8× 179 0.8× 24 0.2× 21 837

Countries citing papers authored by Hiroki Kusumoto

Since Specialization
Citations

This map shows the geographic impact of Hiroki Kusumoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Kusumoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Kusumoto more than expected).

Fields of papers citing papers by Hiroki Kusumoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroki Kusumoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Kusumoto. The network helps show where Hiroki Kusumoto may publish in the future.

Co-authorship network of co-authors of Hiroki Kusumoto

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroki Kusumoto. A scholar is included among the top collaborators of Hiroki Kusumoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroki Kusumoto. Hiroki Kusumoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kusumoto, Hiroki, Jun Ito, Kan-ichi Nakagawara, et al.. (2022). Role of circulating tumor cell clusters in patients with metastatic hormone-sensitive prostate cancer receiving a gonadotropin-releasing hormone antagonist: A pilot study. Asian journal of urology. 10(2). 210–212. 1 indexed citations
2.
Takeda, Takashi, et al.. (2022). Development of 12MW Cross-Shaped Semi-Submersible Floating Offshore Wind Turbine. 1 indexed citations
3.
Ito, Jun, et al.. (2021). Use of the SAND balloon catheter for safe and easy laparoscopic removal of adrenal cysts. IJU Case Reports. 4(6). 371–374. 3 indexed citations
4.
Kaiho, Yasuhiro, et al.. (2020). Sixty‐minute uroflowmetry: A pilot study. International Journal of Urology. 27(11). 1050–1051.
5.
Nishizawa, Satoshi, Yoshihiko Hirohashi, Hiroki Kusumoto, et al.. (2017). Identification of antigenic peptides from novel renal cancer stem-like cell antigen, DNAJB8. Biochemical and Biophysical Research Communications. 494(3-4). 693–699. 2 indexed citations
6.
Yamashita, Masamichi, Yoshihiko Hirohashi, Toshihiko Torigoe, et al.. (2016). Dnajb8, a Member of the Heat Shock Protein 40 Family Has a Role in the Tumor Initiation and Resistance to Docetaxel but Is Dispensable for Stress Response. PLoS ONE. 11(1). e0146501–e0146501. 28 indexed citations
7.
Yamashita, Shimpei, Yasuo Kohjimoto, Takashi Iguchi, et al.. (2016). Prognostic factors and risk stratification in patients with castration-resistant prostate cancer receiving docetaxel-based chemotherapy. BMC Urology. 16(1). 13–13. 14 indexed citations
8.
9.
Kusumoto, Hiroki, et al.. (2012). Numerical Simulation of Liquid Motion In SPB Tank. The Twenty-second International Offshore and Polar Engineering Conference. 2 indexed citations
10.
Morgan, Susan E., Ryungsa Kim, Uppoor G. Bhat, et al.. (2000). Differences in mutant p53 protein stability and functional activity in teniposide-sensitive and -resistant human leukemic CEM cells. Oncogene. 19(43). 5010–5019. 25 indexed citations
11.
Kusumoto, Hiroki, et al.. (1992). A CASE OF MECKEL'S DIVERTICULUM COMPLICATED WITH STRANGULATION OF THE SMALL INTESTINE CAUSED BY A MESODIVERTICULAR BAND. The journal of the Japanese Practical Surgeon Society. 53(3). 639–643. 1 indexed citations
12.
Maehara, Yoshihiko, Yoshihisa Sakaguchi, Ikuo Takahashi, et al.. (1992). 5-Fluorouracil's cytotoxicity is enhanced both in vitro and in vivo by concomitant treatment with hyperthermia and dipyridamole. Cancer Chemotherapy and Pharmacology. 29(4). 257–260. 9 indexed citations
13.
Kusumoto, Hiroki, et al.. (1992). Relationship between tumor histopathology and in vitro sensitivity to antitumor drugs in gastric cancer. Anti-Cancer Drugs. 3(1). 33–38. 5 indexed citations
14.
Kusumoto, Hiroki, Motofumi Yoshida, Ikuo Takahashi, et al.. (1992). Complications and diagnosis of Meckel's diverticulum in 776 patients. The American Journal of Surgery. 164(4). 382–383. 156 indexed citations
15.
Maehara, Yoshihiko, Yasunori Emi, Sunao Moriguchi, et al.. (1992). Postoperative chemotherapy for patients with advanced gastric cancer. The American Journal of Surgery. 163(6). 577–580. 13 indexed citations
16.
Maehara, Yoshihiko, Tetsuya Kusumoto, Hiroki Kusumoto, et al.. (1990). 5-fluorouracil and uft-sensitive gastric carcinoma has a high level of thymidylate synthase. Cancer. 63(9). 1693–1696. 25 indexed citations
17.
Maehara, Yoshihiko, Yoshihisa Sakaguchi, Tetsuya Kusumoto, Hiroki Kusumoto, & Keizō Sugimachi. (1989). Species differences in substrate specificity of pyrimidine nucleoside phosphorylase. Journal of Surgical Oncology. 42(3). 184–186. 18 indexed citations
18.
Maehara, Yoshihiko, Tetsuya Kusumoto, Yoshihisa Sakaguchi, et al.. (1989). Pyrimidine nucleotide synthesis is more extensive in poorly differentiated than in well-differentiated human gastric carcinoma. Cancer. 63(1). 96–101. 18 indexed citations
19.
Maehara, Yoshihiko, Tetsuya Kusumoto, Hiroki Kusumoto, Hideaki Anai, & Keizō Sugimachi. (1989). In vitro Sensitivity of Various Human Tumors to, l-Beta-D-Arabinofuranosylcytosine and, N<sup>4</sup>-Behenoyl-l-Beta-D-Arabinofuranosylcytosine. Chemotherapy. 35(3). 181–186. 1 indexed citations
20.
Anai, Hideaki, Yoshihiko Maehara, Hiroki Kusumoto, & Keizō Sugimachi. (1987). Comparison between Succinate Dehydrogenase Inhibition Test and Subrenal Capsule Assay for Chemosensitivity Testing. Oncology. 44(2). 115–117. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zuli Yang Breakdown of academic impact, for papers by Koushiro Ohtsubo Breakdown of academic impact, for papers by Kanenori Endo Breakdown of academic impact, for papers by Özgül Sağol Breakdown of academic impact, for papers by R. Kath Breakdown of academic impact, for papers by Nigel C. Bird Breakdown of academic impact, for papers by Xiang Hu Breakdown of academic impact, for papers by Liangliang Wu Breakdown of academic impact, for papers by Martin Werner
Rankless by CCL
2026